Table of Contents 1 Rheumatoid Arthritis (RA) Drugs Market Overview 1.1 Product Overview and Scope of Rheumatoid Arthritis (RA) Drugs 1.2 Classification of Rheumatoid Arthritis (RA) Drugs by Type 1.2.1 Global Rheumatoid Arthritis (RA) Drugs Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type in 2019 1.2.3 Oral 1.2.4 Injection 1.2.5 External 1.3 Global Rheumatoid Arthritis (RA) Drugs Market by Application 1.3.1 Overview: Global Rheumatoid Arthritis (RA) Drugs Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Medical Care 1.3.3 Personal Care 1.4 Global Rheumatoid Arthritis (RA) Drugs Market by Regions 1.4.1 Global Rheumatoid Arthritis (RA) Drugs Market Size by Regions: 2015 VS 2019 VS 2025 1.4.2 Global Market Size of Rheumatoid Arthritis (RA) Drugs (2015-2025) 1.4.3 North America (USA, Canada and Mexico) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2015-2025) 1.4.4 Europe (Germany, France, UK, Russia and Italy) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2015-2025) 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2015-2025) 1.4.6 South America (Brazil, Argentina, Colombia) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2015-2025) 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2015-2025) 2 Company Profiles 2.1 AbbVie 2.1.1 AbbVie Details 2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 AbbVie SWOT Analysis 2.1.4 AbbVie Product and Services 2.1.5 AbbVie Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.2 UCB 2.2.1 UCB Details 2.2.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 UCB SWOT Analysis 2.2.4 UCB Product and Services 2.2.5 UCB Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.3 Amgen, Inc. 2.3.1 Amgen, Inc. Details 2.3.2 Amgen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Amgen, Inc. SWOT Analysis 2.3.4 Amgen, Inc. Product and Services 2.3.5 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.4 Roche 2.4.1 Roche Details 2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Roche SWOT Analysis 2.4.4 Roche Product and Services 2.4.5 Roche Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.5 Bristol-Myers Squibb 2.5.1 Bristol-Myers Squibb Details 2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Bristol-Myers Squibb SWOT Analysis 2.5.4 Bristol-Myers Squibb Product and Services 2.5.5 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.6 Johnson & Johnson 2.6.1 Johnson & Johnson Details 2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Johnson & Johnson SWOT Analysis 2.6.4 Johnson & Johnson Product and Services 2.6.5 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.7 Sanofi 2.7.1 Sanofi Details 2.7.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Sanofi SWOT Analysis 2.7.4 Sanofi Product and Services 2.7.5 Sanofi Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.8 Merck 2.8.1 Merck Details 2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Merck SWOT Analysis 2.8.4 Merck Product and Services 2.8.5 Merck Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.9 Pfizer 2.9.1 Pfizer Details 2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 Pfizer SWOT Analysis 2.9.4 Pfizer Product and Services 2.9.5 Pfizer Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.10 GlaxoSmithKline 2.10.1 GlaxoSmithKline Details 2.10.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis 2.10.3 GlaxoSmithKline SWOT Analysis 2.10.4 GlaxoSmithKline Product and Services 2.10.5 GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.11 Abbott Laboratories 2.11.1 Abbott Laboratories Details 2.11.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis 2.11.3 Abbott Laboratories SWOT Analysis 2.11.4 Abbott Laboratories Product and Services 2.11.5 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 2.12 Teva Pharmaceutical 2.12.1 Teva Pharmaceutical Details 2.12.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis 2.12.3 Teva Pharmaceutical SWOT Analysis 2.12.4 Teva Pharmaceutical Product and Services 2.12.5 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2018-2019) 3 Market Competition, by Players 3.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Share by Players (2015-2020) 3.2 Market Concentration Rate 3.2.1 Top 5 Rheumatoid Arthritis (RA) Drugs Players Market Share 3.2.2 Top 10 Rheumatoid Arthritis (RA) Drugs Players Market Share 3.3 Market Competition Trend 4 Market Size by Regions 4.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Market Share by Regions 4.2 North America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 4.3 Europe Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 4.4 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 4.5 South America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 4.6 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 5 North America Rheumatoid Arthritis (RA) Drugs Revenue by Countries 5.1 North America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2015-2020) 5.2 USA Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 5.3 Canada Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 5.4 Mexico Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 6 Europe Rheumatoid Arthritis (RA) Drugs Revenue by Countries 6.1 Europe Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2015-2020) 6.2 Germany Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 6.3 UK Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 6.4 France Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 6.5 Russia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 6.6 Italy Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 7 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Countries 7.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2015-2020) 7.2 China Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 7.3 Japan Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 7.4 Korea Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 7.5 India Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 7.6 Southeast Asia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 8 South America Rheumatoid Arthritis (RA) Drugs Revenue by Countries 8.1 South America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2015-2020) 8.2 Brazil Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 8.3 Argentina Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 9 Middle East & Africa Revenue Rheumatoid Arthritis (RA) Drugs by Countries 9.1 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2015-2020) 9.2 Saudi Arabia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 9.3 UAE Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 9.4 Egypt Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 9.5 South Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) 10 Market Size Segment by Type 10.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Market Share by Type (2015-2020) 10.2 Global Rheumatoid Arthritis (RA) Drugs Market Forecast by Type (2019-2024) 10.3 Oral Revenue Growth Rate (2015-2025) 10.4 Injection Revenue Growth Rate (2015-2025) 10.5 External Revenue Growth Rate (2015-2025) 11 Global Rheumatoid Arthritis (RA) Drugs Market Segment by Application 11.1 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application (2015-2020) 11.2 Rheumatoid Arthritis (RA) Drugs Market Forecast by Application (2019-2024) 11.3 Medical Care Revenue Growth (2015-2020) 11.4 Personal Care Revenue Growth (2015-2020) 12 Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2021-2025) 12.1 Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2021-2025) 12.2 Global Rheumatoid Arthritis (RA) Drugs Market Forecast by Regions (2021-2025) 12.3 North America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) 12.4 Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) 12.5 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) 12.6 South America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) 12.7 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source 14.3 Disclaimer 14.4 About US

List of Tables Table 1. Global Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Rheumatoid Arthritis (RA) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Global Market Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) Comparison by Regions 2015-2025 Table 5. AbbVie Corporate Information, Location and Competitors Table 6. AbbVie Rheumatoid Arthritis (RA) Drugs Major Business Table 7. AbbVie Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 8. AbbVie SWOT Analysis Table 9. AbbVie Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 10. AbbVie Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 11. UCB Corporate Information, Location and Competitors Table 12. UCB Rheumatoid Arthritis (RA) Drugs Major Business Table 13. UCB Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2018-2019) Table 14. UCB SWOT Analysis Table 15. UCB Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 16. UCB Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 17. Amgen, Inc. Corporate Information, Location and Competitors Table 18. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Major Business Table 19. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 20. Amgen, Inc. SWOT Analysis Table 21. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 22. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 23. Roche Corporate Information, Location and Competitors Table 24. Roche Rheumatoid Arthritis (RA) Drugs Major Business Table 25. Roche Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 26. Roche SWOT Analysis Table 27. Roche Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 28. Roche Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 29. Bristol-Myers Squibb Corporate Information, Location and Competitors Table 30. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Major Business Table 31. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 32. Bristol-Myers Squibb SWOT Analysis Table 33. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 34. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 35. Johnson & Johnson Corporate Information, Location and Competitors Table 36. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Major Business Table 37. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 38. Johnson & Johnson SWOT Analysis Table 39. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 40. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 41. Sanofi Corporate Information, Location and Competitors Table 42. Sanofi Rheumatoid Arthritis (RA) Drugs Major Business Table 43. Sanofi Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 44. Sanofi SWOT Analysis Table 45. Sanofi Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 46. Sanofi Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 47. Merck Corporate Information, Location and Competitors Table 48. Merck Rheumatoid Arthritis (RA) Drugs Major Business Table 49. Merck Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 50. Merck SWOT Analysis Table 51. Merck Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 52. Merck Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 53. Pfizer Corporate Information, Location and Competitors Table 54. Pfizer Rheumatoid Arthritis (RA) Drugs Major Business Table 55. Pfizer Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 56. Pfizer SWOT Analysis Table 57. Pfizer Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 58. Pfizer Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 59. GlaxoSmithKline Corporate Information, Location and Competitors Table 60. GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Major Business Table 61. GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 62. GlaxoSmithKline SWOT Analysis Table 63. GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 64. GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 65. Abbott Laboratories Corporate Information, Location and Competitors Table 66. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Major Business Table 67. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 68. Abbott Laboratories SWOT Analysis Table 69. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 70. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 71. Teva Pharmaceutical Corporate Information, Location and Competitors Table 72. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Major Business Table 73. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Total Revenue (USD Million) (2017-2018) Table 74. Teva Pharmaceutical SWOT Analysis Table 75. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product and Solutions Table 76. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 77. Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Players (2015-2020) Table 78. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Players (2015-2020) Table 79. Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Regions (2015-2020) Table 80. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Regions (2015-2020) Table 81. North America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2015-2020) Table 82. North America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2015-2020) Table 83. Europe Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Countries (2015-2020) Table 84. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Countries (2015-2020) Table 85. South America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2015-2020) Table 86. South America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2015-2020) Table 87. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Countries (2015-2020) Table 88. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2015-2020) Table 89. Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Type (2015-2020) Table 90. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Type (2015-2020) Table 91. Global Rheumatoid Arthritis (RA) Drugs Revenue Forecast by Type (2021-2025) Table 92. Global Rheumatoid Arthritis (RA) Drugs Revenue by Application (2015-2020) Table 93. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Application (2015-2020) Table 94. Global Rheumatoid Arthritis (RA) Drugs Revenue Forecast by Application (2021-2025) Table 95. Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) Forecast by Regions (2021-2025) List of Figures Figure 1. Rheumatoid Arthritis (RA) Drugs Picture Figure 2. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type in 2019 Figure 3. Oral Picture Figure 4. Injection Picture Figure 5. External Picture Figure 6. Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application in 2019 Figure 7. Medical Care Picture Figure 8. Personal Care Picture Figure 9. Global Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) and Growth Rate (2015-2025) Figure 10. North America Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2015-2025) Figure 11. Europe Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2015-2025) Figure 12. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2015-2025) Figure 13. South America Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2015-2025) Figure 14. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2015-2025) Figure 15. Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2015-2025) Figure 16. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Players in 2019 Figure 17. Global Top 5 Players Rheumatoid Arthritis (RA) Drugs Revenue Market Share in 2019 Figure 18. Global Top 10 Players Rheumatoid Arthritis (RA) Drugs Revenue Market Share in 2019 Figure 19. Key Players Market Share Trend Figure 20. Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020) Figure 21. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Regions (2015-2020) Figure 22. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Regions in 2018 Figure 23. North America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 24. Europe Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 25. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 26. South America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 27. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 28. North America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2015-2020) Figure 29. North America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2019 Figure 30. USA Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 31. Canada Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 32. Mexico Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 33. Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2015-2020) Figure 34. Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2019 Figure 35. Germany Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 36. UK Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 37. France Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 38. Russia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 39. Italy Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 40. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2015-2020) Figure 41. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2019 Figure 42. China Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 43. Japan Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 44. Korea Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 45. India Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 46. Southeast Asia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 47. South America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2015-2020) Figure 48. South America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2019 Figure 49. Brazil Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 50. Argentina Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 51. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2015-2020) Figure 52. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2019 Figure 53. Saudi Arabia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 54. UAE Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 55. Egypt Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 56. South Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2015-2020) Figure 57. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Type (2015-2020) Figure 58. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Type in 2019 Figure 59. Global Rheumatoid Arthritis (RA) Drugs Market Share Forecast by Type (2021-2025) Figure 60. Global Oral Revenue Growth Rate (2015-2020) Figure 61. Global Injection Revenue Growth Rate (2015-2020) Figure 62. Global External Revenue Growth Rate (2015-2020) Figure 63. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Application (2015-2020) Figure 64. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Application in 2019 Figure 65. Global Rheumatoid Arthritis (RA) Drugs Market Share Forecast by Application (2021-2025) Figure 66. Global Medical Care Revenue Growth Rate (2015-2020) Figure 67. Global Personal Care Revenue Growth Rate (2015-2020) Figure 68. Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025) Figure 69. Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) Forecast by Regions (2021-2025) Figure 70. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share Forecast by Regions (2021-2025) Figure 71. North America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) Figure 72. Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) Figure 73. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) Figure 74. South America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) Figure 75. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2021-2025) Figure 76. Sales Channel: Direct Channel vs Indirect Channel

AbbVie UCB Amgen, Inc. Roche Bristol-Myers Squibb Johnson & Johnson Sanofi Merck Pfizer GlaxoSmithKline Abbott Laboratories Teva Pharmaceutical